Litcius/Paper detail

CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma

Feifei Hu, Hao Chen, Yang Duan, Bei Lan, Chunjie Liu, Hui Hu, Dong Xu, Qiong Zhang, Yiming Cheng, Min Liu, An‐Yuan Guo, Chenghao Xuan

2021Molecular Therapy — Nucleic Acids48 citationsDOIOpen Access PDF

Abstract

. The combined high expression of CBX2 and EZH2 was an indicator of poor prognosis in LUAD. The inhibition of both CBX2 and EZH2 exerted cooperative suppressive effects on the growth and metastasis of LUAD cells. Mechanistically, we revealed that CBX2 and EZH2 downregulated several PPAR signaling pathway genes and tumor suppressor genes through binding to their promoter cooperatively or separately. Furthermore, knockdown of CBX2 improved the therapeutic efficiency of EZH2 inhibitor on A549 cells. Our study reveals the cooperative oncogenic role of CBX2 and EZH2 in promoting LUAD progression, thereby providing potential targets for LUAD diagnosis and therapy.

Topics & Concepts

EZH2Gene knockdownCancer researchEpigeneticsBiologyHistoneHistone methyltransferaseAdenocarcinomaMetastasisH3K4me3Regulation of gene expressionHistone methylationDNA methylationCancerGene expressionPromoterGeneGeneticsEpigenetics and DNA MethylationCancer-related gene regulationRNA modifications and cancer
CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma | Litcius